Blood-Derived Products for Chronic, Non-Healing Wounds
Guidance for the non-coverage determination for the use of Autologous PRP for the use of autologous blood-derived products for the treatment of chronic, non-healing wounds (autologous platelet rich plasma (PRP)) for treatment of acute wounds where PRP is applied directly to the closed incision site, and for dehiscent wounds.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: May 02, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.